Reasoned therapeutic protocol in outpatients with COVID-19
| Autor: | Ferdinando Mannello, Giacomo Failla, Francesco Montella, Luca Costanzo, Pier Luigi Antignani, C. Allegra |
|---|---|
| Rok vydání: | 2021 |
| Předmět: |
Male
Prodromal Period medicine.medical_specialty Coronavirus disease 2019 (COVID-19) Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) MEDLINE Comorbidity Disease 030204 cardiovascular system & hematology 030230 surgery Asymptomatic 03 medical and health sciences 0302 clinical medicine Clinical Protocols Internal medicine Outpatients medicine Humans Protocol (science) SARS-CoV-2 business.industry Age Factors COVID-19 Female Hospitalization Italy Review Literature as Topic Risk Reduction Behavior medicine.disease COVID-19 Drug Treatment medicine.symptom Cardiology and Cardiovascular Medicine business |
| Zdroj: | International Angiology. 40 |
| ISSN: | 1827-1839 0392-9590 |
| DOI: | 10.23736/s0392-9590.21.04556-9 |
| Popis: | Background Seventy percent of patients affected by SARS-COV-2 disease are asymptomatic or with symptoms that not required Hospitalization. A prodromal period lasting about 5 days can be identified. In this phase a patient with a positive swab for viral RNA may or may not evolve towards the phase of symptomatic disease. Methods In this paper we reviewed the literature related to COVID-19 therapy we propose a reasoned treatment protocols in outpatients according to the age and the comorbidity. Results The aim of this study was to reduce the impact of the virus by reducing its ability to attack cells and the inflammatory burden and the prothrombotic effects proposing two therapeutic schemes of proven efficacy according to the age of the patients and the comorbidities. Conclusions We aimed to reduce worsening of clinical status and hospitalization while protecting patients at home. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|